Sort by
Refine Your Search
-
, Neuroscience and Rare Diseases. Our presence in North America dates back to 1976, and includes Ipsen’s third global hub right in the heart of the leading global biotech ecosystem in Cambridge, Mass., where a
-
; materials may include creative campaign, core / interactive visual aids, digital content, content for peer-to-peer tactics, and training programs associated with content/skills required for optimal patient
-
or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture: Our people-first culture is guided by our core
-
researchers in knowledge-centric and human-focused AI. The five thematic areas, as well as the core hiring and mentoring committee, are described below. Themes: The cohort of five is envisaged to comprise hires
-
innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. With a seasoned GI leadership team at the helm, deep
-
history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs. With a seasoned GI leadership team
-
of neuropathic pain, glaucoma, substance use disorder, epilepsy and other disorders. Responsibilities: As a member of a this research team, this Research Scientist is expected to execute across all aspects